| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |